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Different substituted pyridinium N-heteroarylaminides have been prepared in one step from N-amino-
pyridinium iodide and the corresponding heteroaryl halide by two alternative routes. The use of Pd
catalysis allowed the easy preparation of products from the less reactive haloheterocycles. The use of
water as a solvent in conjunction with microwave heating dramatically diminishes the reaction time
without having an adverse effect on reaction yields.
 2008 Elsevier Ltd. All rights reserved.1. Introduction
Mesomeric betaines are neutral conjugated molecules that can
only be represented by canonical formulae in which two opposite
charges are delocalized within the p-electron system.1 Some
heterocyclic betaines are useful in medicinal chemistry because of
their pharmacological activities and low toxicity.2 Moreover, the
structural features of this class of compounds suggest a high
probability of interactions with biomoleculesde.g., DNA, pro-
teinsdand they can therefore cross biological membranes
in vivo.3
Conjugated heterocyclic N-ylides 1 (Fig. 1), a subgroup of
mesomeric betaines, have been widely used as building blocks for
the synthesis of fused heterocyclic systems and natural products.
This application is due mostly to their 1,3-dipolar character,4 which
allows cycloaddition processes to take place efﬁciently. Today,
cycloimmonium ylidesdincluding azomethine imines, usually
described as N-aminides 1c (Fig. 1)dare involved in a wide rangeN
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All rights reserved.of synthetically useful reactions in the ﬁeld of heterocyclic
chemistry.2,5
For several years, part of our research program has been devoted
to the study of pyridinium heteroaryl-stabilized aminides 2 (Fig. 1).
These compounds have proven to be useful intermediates in het-
erocyclic synthesis and this is due to their particular structure, in
which a positively charged pyridinium ring is linked to a negatively
charged 2-aminoheteroaryl moiety.6 The whole structure is stable
and, having compensated charges, is lipophilic and soluble in
moderately polar solvents.
The synthesis of N-aminide intermediates 2 has commonly been
performed by the reaction of 2,4-dinitrophenylpyridinium chloride
with the corresponding 2-heteroaryl hydrazine in a typical
ANRORC process that yields the hydrazone. Acid catalysis then
produces the pyridinium salts, which are ﬁnally transformed into
the N-aminides 2 by treatment with base. This method,6b adapted
from that previously described by Beyer,7 is suitable for commer-
cially available heteroaryl-derivativesdusually the simpler
pyridylhydrazines.
Recently, we developed a method to prepare pyridinium
N-heteroarylaminides in one step from the commercially available
N-aminopyridinium iodide 3 and the corresponding heteroaryl
chloride 4 (X¼Cl) (Scheme 1).6j The procedure proved to be useful
on using p-deﬁcient heteroaryl chlorides that are more activated
than 2-chloropyridine, but the procedure did not work when the
heterocycle was less activated for nucleophilic substitution.N
N
NI
K2CO3
CH3CN N
NH
N
NH2
++
3
Het
+
_
NX
Het
4
2
_
_
Scheme 1.
Table 1
Comparative yields for compounds 2a–ad
Compound Het- X Methoda
(reaction time)
Yield (%)b Compound Het- X Methoda
(reaction time)
Yieldb (%)
2a6b
N
Br B (22 h) 90
2p6j
NN
Ph
Cl
A (4 h) 53
Br C (10 min) 24
Cl B (31 h) 33 C (10 min) 88
Cl C (10 min) 35
2b
N
CH3
Br B (25 h) 76 2q6b,j
N
N
Cl
A (4 h) 95
C (10 min) 80
2c6c
N
Br
Br B (39 h) 38 2r
N
N
Br
Cl A (14 h) 76
2d
N
OH3C
Br B (39 h) 30 2s6j
Cl
N
N
Cl
A (20 h) 95
C (10 min) 34
2e6j
N Cl
Cl
A (4 h) 65
2t
N
N S
CH3 Cl B (20 h) 50
C (10 min) 50
2f6b,j
N
NO2
Cl
A (4 h) 75
2u6j
Cl
N
N
CH3
Cl
A (24 h) 98
C (10 min) 72 C (10 min) 96
2g6j
N
O2N
Cl
A (24 h) 70
2v6j
Cl
N
N
Cl
Cl
A (7 h) 75
C (10 min) 75 C (10 min) 85
2h N N
Br
Br
A (17 h) 34
2w
N
N
Br B (32 h) 50
B (7 h) 30
2i6b
N
Cl
A (5 h) 40
2x6b,j
N
N
Cl
A (4 h) 72
B (31 h) 50 C (10 min) 75
C (10 min) 76
2j
N
Cl
A (5 h) 64
2y6j
N
N
Cl
Cl
A (20 h) 95
C (10 min) 70 C (10 min) 84
2k N Cl
A (16 h) 40
2z6j
N
N Cl
Cl
A (20 h) 77
C (10 min)C (10 min) 80 86
2l N
Cl
Cl A (6 h) 90 2aa
N
N
Cl
A (16 h) 84
B (25 h) 25
C (10 min) 76
2m
N
Br B (30 h) 63 2ab
N
S
Br B (30 h) 45
2n
N
CH3
N
O
Cl B (25 h) 30 2ac
N
S
NO2 Br A (21 h) 78
2o6j
NN
Cl
Cl
A (15 h) 91
2ad
N
S
O
O CH3 Br A (21 h) 2090C (10 min)
a Method A: N-aminopyridinium iodide (4.5 mmol), aryl halide (4.7 mmol), and potassium carbonate (13.5 mmol) in acetonitrile as solvent. Method B: N-aminopyridinium
iodide (0.56 mmol), aryl halide (0.37 mmol), sodium tert-butoxide (2.25 mmol), Pd2(dba)3 (5 mmol %), and BINAP (5 mmol %) in toluene as solvent. Method C: N-amino-
pyridinium iodide (0.37 mmol), aryl halide (0.39 mmol), and potassium carbonate (1.12 mmol) in water at 170 C using MW.
b Yields for isolated pure product.
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In attempts to apply the previously reported one-step synthesis
of pyridinium N-heteroarylaminides 2 to other types of stabilizing
heterocycles, we found that bicyclic haloazines like 2- and 4-
chloroquinoline, 1-chloroisoquinoline, 1,3-dichloroisoquinoline,and 2-chloroquinoxaline reacted with N-aminopyridinium iodide
to yield the corresponding N-aminides 2i–l and 2aa (see Table 1
and Scheme 2, method A). The result was consistent with the fact
that halo-benzoheterocycles are more susceptible to nucleophilic
substitution processes. The best yields were obtained for com-
pounds 2l and 2aa, when a more reactive heteroaryl chloride was
M. Co´rdoba et al. / Tetrahedron 64 (2008) 7914–79197916employed. Two new heteroarylaminides, 2ac and 2ad, stabilized by
a thiazole ring were also obtained by this method starting from the
corresponding bromo-derivatives 4 (X¼Br). As expected, the elec-
tronic effect of substituents was clear, and 2-bromo-5-nitrothiazole
gave a better yield (78%) than ethyl 2-bromothiazole-5-carboxylate
(see Table 1). Aminide 2h was obtained in an attempt to achieve
double coupling on 6,60-dibromo[2,20]bipyridinyl. Compound 2r,
previously prepared by bromination of 2q,6c,r was also obtained in
one step and with an increased yield from 5-bromo-2-
chloropyrimidine.
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Scheme 2.With the aim of expanding the synthesis of pyridinium N-het-
eroarylaminides 2, and bearing in mind that palladium-catalyzed
amination of aryl halides has become a versatile method for the
preparation of arylamines,8 we accomplished the formation of a
C–N bond between several haloheterocycles andN-aminopyridinium
iodide using a palladium-catalyzed amination process (Scheme 2,
method B).
2-Bromopyridine, a substrate that did not yield aminide 2a by
the conventional method,6j was chosen for the initial amination
experiments in toluene at 80–110 C.9 The use of the soft bases
Cs2CO3 or K2CO3,
10 which produce good results in Suzuki coupling
on pyridinium N-haloheteroarylaminides,6k,n,q in conjunction with
Pd2(dba)3, Pd(OAc)2 or Pd(PPh3)4 as catalysts and in the presence or
absence of complexing agents, e.g., 2,20-bis(diphenylphosphino)-
1,10-binaphthyl (BINAP) or 2-(di-tert-butylphosphine)biphenyl, did
not produce the desired coupling. The ﬁrst encouraging result was
achieved with N-aminopyridinium iodide (1.5 equiv) and 2-bro-
mopyridine (1 equiv) in toluene at 80 C, with Pd2(dba)3 (5 mol %)
as the catalyst and 2-(di-tert-butylphosphine)biphenyl (5 mol %)
with sodium tert-butoxide (NaOtBu) (6 equiv) as the base.11 Under
these conditions, compound 2a6b was obtained in 33% yield. A
change in the phosphine to BINAP improved the yield of 2a to 90%.
On applying these standard conditions (method B) to other com-
mercially available bromo- or chloro-heterocycles, compounds 2h–
i, 2aa and some new stabilized pyridinium N-heteroarylaminides
(2b–d, 2n, 2t, and 2ab) were obtained in moderate to low yields. In
general, chloro-derivatives gave rise to lower yields (see Table 1).
Two non-stabilized pyridium aminides (2w and 2m) were also
prepared in this way.
Finally, a change in the synthetic route for aminides 2 to a more
environmentally friendly methodology was investigated. The use of
water in conjunction with microwaves in organic synthesis has
become increasingly popular in recent years12 and we therefore
decided to test the reaction between N-aminopyridinium iodide,
anhydrous potassium carbonate, and chloro-heterocycles in water
in a microwave system.
The study began with 2-chloroquinoline, a substrate that pro-
duced 2i in reasonable yields by methods A and B (see Table 1 and
Scheme 2) and was selected here to optimize reaction time and
temperature. Preliminary results showed that, at 100 C, changes in
reaction time from 10 to 20 min did not improve reaction yields, as
determined by HPLC–MS. However, when the temperature was
raised to 150 C the conversion increased from 17 to 45% in 10 min.On the basis of these results, the reaction time was ﬁxed at 10 min
and additional optimization experiments were performed to
modify the reaction temperature with or without simultaneous
cooling (CEM PowerMAXmethodology).13 The best conditions gave
conversions of 65% and these were obtained at 170 C without
external cooling. Higher temperatures produced a clear reduction
in yield and a charred reaction mixture was obtained at 200 C. A
series of N-aminides 2e–g, 2i–k, 2o–q, 2s, 2u–v, 2x–z, and 2aa (see
Table 1, method C) were synthesized according to this green
methodology (Scheme 2), which reduces reaction times from hours
(4–39 h) to 10 min without appreciable changes in yield.
The N-aminide 2a was also obtained by this method but, as
expected due to the absence of electron-withdrawing substituents,
the yield was considerably lower than that obtained previously by
method B (see Table 1).
3. Conclusions
In an effort to expand an easy preparation of pyridinium
N-heteroarylaminides 2, three methods have been compared: one
in which the aromatic substitution is produced using base and the
conventional acetonitrile reﬂux (method A), a second approach
using Pd catalysis (method B), and a third method using water as
solvent, base, and microwave irradiation (method C). Method B is
a new one-step amination procedure that provided the corre-
sponding N-aminides from haloheterocycles without electron-
withdrawing substituents (see 2n) and even with the halogen
located in positions that were not conjugated with nitrogen (see
2m,w). In most cases, however, only moderate yields were
obtained. Finally, method C is a green methodology that avoids the
use of palladium and hard bases, with water used as a cheap and
non-toxic solvent in conjunction with microwave heating, an
approach that produces good yields and requires much shorter
reaction times.
4. Experimental
4.1. General remarks
All melting points were determined in open capillary tubes on
a Stuart Scientiﬁc SMP3 melting point apparatus and are un-
corrected. IR spectra were obtained on a Perkin–Elmer FTIR spec-
trum 2000 spectrophotometer. 1H NMR spectra were recorded on
Varian Unity 300 (300 MHz) and Varian Mercury-VX (500 MHz)
spectrometers at ambient temperature. 13C NMR spectra were
recorded on Varian Unity 300 (75 MHz) and Varian Mercury-VX
(125 MHz) spectrometers at ambient temperature. Chemical shifts
are given in parts per million (d) downﬁeld from TMS. Coupling
constants (J) are in hertz (Hz) and signals are described as follows:
s, singlet; d, doublet; t, triplet; m, multiplet; br, broad; ap, apparent.
HPLC–MS analyses were performed on an Agilent 1100 apparatus. A
Luna C18 (1504.6 mm) 3 mm Phenomenex chromatographic col-
umn was used with a mobile phase formed by a triple gradient of
4% aq formic acid (A), water (B), and acetonitrile (C). The gradient
started as A (2.5%), B (93%), and C (4.5%) and in 30 min reached A
(2.5%), B (4.5%), and C (93%). In the mass detector, the fragmenter
operated at 70 eV. Low-resolution mass spectra (MS) were recor-
ded on a Hewlett–Packard 5988A spectrometer using electronic
impact (EI) or electrospray (ESI) and high-resolution analysis (TOF)
was performed on an Agilent 6210 time-of-ﬂight LC/MS. All re-
agents were obtained from commercial sources and were used
without further puriﬁcation. Solvents were puriﬁed and dried by
standard procedures. Column chromatography was carried out
with silica gel 60 (40–63 mm, Merck) columns, using the eluent
quoted in each case. All microwave experiments were carried out in
a CEM Explorer PLS, a single mode operating system, working at
M. Co´rdoba et al. / Tetrahedron 64 (2008) 7914–7919 79172.45 GHz, with a power programmable from 1 to 300 W. Magnetic
stirring was performed at 400 rpm, the only stirring speed allowed
by the apparatus.
4.2. General procedures for the preparation of pyridinium N-
(heteroaryl) aminides (2)
4.2.1. Method A
Potassium carbonate (1.86 g,13.5 mmol) was added to a solution
of N-aminopyridinium iodide (1 g, 4.5 mmol) in acetonitrile
(20 mL) and the reaction mixture was vigorously stirred for 45 min
at room temperature to give a purple solution. To the reaction
mixturewas added a solution of the corresponding haloheterocycle
(4.7 mmol) in acetonitrile (5 mL). The mixture was stirred and
heated under reﬂux until all starting material had been consumed
(detected by TLC). The inorganic salts were ﬁltered through Celite
and the ﬁltrate was evaporated in vacuo. The product was puriﬁed
by chromatography on silica gel using ethanol as eluent. The solid
was crystallized from the appropriate solvent and identiﬁed.
4.2.2. Method B
A round-bottomed ﬂask was charged with heteroaryl halide
(0.37 mmol), sodium tert-butoxide (0.22 g, 2.25 mmol), BINAP
(5 mol %), and N-aminopyridinium iodide (0.125 g, 0.56 mmol). The
mixture was ﬂushed with argon for 10 min. Dry toluene (10 mL)
and Pd2(dba)3 (5 mol %) were added. The mixture was stirred and
heated under reﬂux until the starting material had been consumed
(detected by TLC). The inorganic salts were ﬁltered through Celite
and the ﬁltrate was evaporated in vacuo. The product was puriﬁed
by chromatography on silica gel using ethanol as eluent. The solid
was crystallized from the appropriate solvent and identiﬁed.
4.2.3. Method C
Potassium carbonate (0.15 g, 1.12 mmol), N-aminopyridinium
iodide (0.083 g, 0.37 mmol), the corresponding haloheterocycle
(0.39 mmol), and water (0.5 mL) were placed in a standard CEM
10 mL pressurized reaction vial. The reaction mixture was then
magnetically stirred and irradiated in the microwave system at
170 C for 10 min. The solvent was removed under vacuum and the
product was puriﬁed by chromatography on silica gel, using ethanol
as eluent, with the exception of compounds 2s and 2t, which pre-
cipitated from the reaction mixture and were recovered by ﬁltra-
tion. Finally, the products were crystallized from the appropriate
solvent and identiﬁed.
The following compounds were prepared according to one or
more of the general methods described before.
4.2.3.1. N-(Pyridin-2-yl)pyridinium aminide 2a. See Ref. 6b.
4.2.3.2. N-(5-Methylpyridin-2-yl)pyridinium aminide 2b. Orange
solid, mp 94–96 C (ethanol); IR (KBr) nmax (cm1): 1599, 1463,
1374, 1320, 1285, 1147, 806, 669; 1H NMR (300 MHz, CD3OD): d 8.76
(2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 7.99 (1H, tt, J¼7.7 and 1.3 Hz, H4),
7.79 (2H, dd, J¼7.7 and 7.0 Hz,H3(5)), 7.55 (1H, m,H60), 7.30 (1H, dd,
J¼8.6 and 2.4 Hz, H40), 6.52 (1H, d, J¼8.6 Hz, H30), 2.15 (3H, s, CH3);
13C NMR (75 MHz, CD3OD): d 163.4, 145.7, 144.0, 140.1, 137.1, 128.5,
121.8, 112.3, 17.5. MS (EI, m/z): 185 (31, Mþ), 184 (86), 105 (11), 79
(44), 52 (100); HRMS (ESI-TOF, CH3OH): calcd for C11H12N3 [MþH]þ,
186.10257; found, 186.10226.
4.2.3.3. N-(5-Bromopyridin-2-yl)pyridinium aminide 2c. See Ref. 6c.
4.2.3.4. N-(3-Methoxypyridin-2-yl)pyridinium aminide 2d. Orange
solid, mp 181–183 C (ethanol); IR (KBr) nmax (cm1): 1593, 1465,
1442,1420,1209,1179,1109,1003, 745; 1H NMR (300 MHz, CD3OD):
d 8.72 (2H, dd, J¼6.9 and 1.3 Hz, H2(6)), 8.07 (1H, tt, J¼7.7 and1.3 Hz, H4), 7.83 (2H, dd, J¼7.7 and 6.9 Hz, H3(5)), 7.28 (1H, dd,
J¼5.3 and 1.5 Hz, H60), 6.96 (1H, dd, J¼7.7 and 1.5 Hz, H40), 6.45 (1H,
dd, J¼7.7 and 5.3 Hz, H50), 3.89 (3H, s, CH3); 13C NMR (75 MHz,
CD3OD): d 157.4, 145.4, 145.1, 138.3, 137.5, 128.5, 115.4, 112.1, 55.6.
MS (EI, m/z): 201 (66, Mþ), 200 (100), 107 (64), 80 (59), 67 (19), 53
(38), 52 (31); HRMS (ESI-TOF, CH3OH): calcd for C11H12N3O
[MþH]þ, 202.09749; found, 202.09668.
4.2.3.5. N-(6-Chloropyridin-2-yl)pyridinium aminide 2e. See Ref. 6j.
4.2.3.6. N-(5-Nitropyridin-2-yl)pyridinium aminide 2f. See Ref. 6b.
4.2.3.7. N-(3-Nitropyridin-2-yl)pyridinium aminide 2g. See Ref. 6j.
4.2.3.8. N-(60-Bromo[2,20]bipyridin-6-yl)pyridinium aminide
2h. Yellow solid, mp 190–192 C (ethanol/ethyl acetate); IR (KBr)
nmax (cm
1): 1570, 1547, 1431, 1412, 1353, 1268, 1237, 1139, 1124,
980, 784, 666; 1H NMR (300 MHz, CD3OD): d 8.93 (2H, dd, J¼6.9 and
1.3 Hz, H2(6)), 8.06 (1H, tt, J¼7.6 and 1.3 Hz, H4), 7.85 (2H, dd, J¼7.6
and 6.9 Hz, H3(5)), 7.84 (1H, dd, J¼7.6 and 1.0 Hz, H300), 7.59 (1H, t,
J¼7.7 Hz, H400), 7.48 (3H, m, H30, H40 and H500), 6.60 (1H, dd, J¼8.1
and 1.1 Hz, H50); 13C NMR (75 MHz, CD3OD): d 164.5, 159.6, 152.1,
144.6, 142.2, 140.4, 138.8, 137.6, 128.2, 127.9, 120.1, 113.0, 110.7. MS
(EI, m/z): 326/328 (50/51, Mþ), 325/327 (90/100), 249/251 (13/12),
246 (48), 194 (16), 170 (43), 141 (29), 114 (26), 79 (49), 52 (36);
HRMS (ESI-TOF, CH3OH): calcd for C15H12
79BrN4 [MþH]þ, 327.0245;
found, 327.0250.
4.2.3.9. N-(Quinolin-2-yl)pyridinium aminide 2i. See Ref. 6b.
4.2.3.10. N-(Quinolin-4-yl)pyridinium aminide 2j. Orange solid, mp
93–95 C (ethanol/ethyl acetate); IR (KBr) nmax (cm1): 1647, 1618,
1601, 1539, 1494, 1468, 1389, 1354, 1136, 789, 745, 674; 1H NMR
(300 MHz, CD3OD): d 8.85 (2H, dd, J¼6.7 and 1.4 Hz, H2(6)), 8.47
(1H, br d, J¼8.2 Hz,H80), 8.36 (1H, tt, J¼7.8 and 1.4 Hz,H4), 8.06 (2H,
dd, J¼7.8 and 6.7 Hz, H3(5)), 7.68 (1H, ddd, J¼8.1, 6.8, and 1.4 Hz,
H70), 7.62 (1H, dd, J¼8.1 and 1.6 Hz, H50), 7.51 (1H, ddd, J¼8.3, 6.8,
and 1.2 Hz, H60), 7.25 (1H, d, J¼6.6 Hz, H20), 6.71 (1H, d, J¼6.6 Hz,
H30); 13C NMR (75 MHz, CD3OD): d 145.7, 141.5, 138.3, 134.8, 132.5,
129.9,129.8,127.5,127.2,126.2,122.4,109.4. MS (ESI,m/z): 222 (100,
Mþ1), 220 (28), 143 (18); HRMS (ESI-TOF, CH3OH): calcd for
C14H12N3 [MþH]þ, 222.1031; found, 222.1044.
4.2.3.11. N-(Isoquinolin-1-yl)pyridinium aminide 2k. Orange solid,
mp 138–140 C (ethanol/ethyl acetate); IR (KBr) nmax (cm1): 1612,
1583, 1540, 1495, 1472, 1391, 1356, 1157, 1136, 789, 750, 676; 1H
NMR (300 MHz, CD3OD): d 8.83 (2H, dd, J¼6.9 and 1.3 Hz, H2(6)),
8.44 (1H, br dd, J¼8.2 and 0.9 Hz, H80), 8.30 (1H, tt, J¼7.8 and 1.3 Hz,
H4), 8.02 (2H, dd, J¼7.8 and 6.9 Hz, H3(5)), 7.65 (1H, ddd, J¼7.9, 6.4,
and 1.3 Hz, H60), 7.60 (1H, br dd, J¼7.9 and 2.0 Hz, H50), 7.49 (1H,
ddd, J¼8.2, 6.4, and 1.8 Hz,H70), 7.32 (1H, d, J¼6.4 Hz,H30), 6.71 (1H,
br d, J¼6.4 Hz,H40); 13C NMR (75 MHz, CD3OD): d 162.8,146.1,140.3,
138.8, 138.5, 131.6, 129.3, 126.9, 126.7, 125.9, 122.0, 109.4. MS (ESI,
m/z): 222 (100, Mþ1), 220 (9), 143 (24); HRMS (ESI-TOF, CH3OH):
calcd for C14H12N3 [MþH]þ, 222.1031; found, 222.1045.
4.2.3.12. N-(3-Chloroisoquinolin-1-yl)pyridinium aminide
2l. Orange solid, mp 133–135 C (ethanol/ethyl acetate); IR (KBr)
nmax (cm
1): 1579, 1486, 1474, 1407, 1381, 1139, 671; 1H NMR
(300 MHz, CD3OD): d 8.84 (2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 8.33
(1H, br dd, J¼8.4 and 1.2 Hz, H80), 8.21 (1H, tt, J¼7.8 and 1.3 Hz, H4),
7.94 (2H, dd, J¼7.8 and 7.0 Hz, H3(5)), 7.56 (1H, ddd, J¼8.1, 6.8, and
1.2 Hz, H60), 7.49 (1H, dd, J¼8.1 and 1.5 Hz, H50), 7.39 (1H, ddd,
J¼8.4, 6.7, and 1.5 Hz, H70), 6.66 (1H, s, H40); 13C NMR (75 MHz,
CD3OD): d 163.5, 146.0, 145.4, 140.6, 139.8, 131.4, 128.6, 126.1, 126.0,
125.7, 120.1, 106.2. MS (ESI, m/z): 256/258 (100/36, Mþ1), 177 (25);
M. Co´rdoba et al. / Tetrahedron 64 (2008) 7914–79197918HRMS (APCI): calcd for C14H11
35ClN3 [MþH]þ, 256.0642; found,
256.0641.
4.2.3.13. N-(Isoquinolin-4-yl)pyridinium aminide 2m. Dark red
solid, mp 159–161 C (ethanol/ethyl acetate); IR (KBr) nmax (cm1):
1558, 1489, 1465, 1457, 1396, 1320, 1124, 678, 668; 1H NMR
(300 MHz, CD3OD): d 8.83 (2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 8.50
(1H, s, H10), 8.31 (1H, m, H80), 8.14 (1H, tt, J¼7.8 and 1.3 Hz,H4), 7.96
(1H, m, H50), 7.91 (2H, dd, J¼7.8 and 7.0 Hz, H3(5)), 7.69 (2H, m, H60
andH70), 7.29 (1H, s,H30); 13C NMR (75 MHz, CD3OD): d 146.2,145.7,
143.2, 142.2, 131.9, 130.3, 129.6, 129.1, 129.0, 125.9 (two overlapped
signals), 122.5. MS (EI, m/z): 221 (15, Mþ), 144 (19), 142 (24), 115
(40), 80 (65), 79 (100), 52 (80); HRMS (ESI-TOF, CH3OH): calcd for
C14H12N3 [MþH]þ, 222.1031; found, 222.1022.
4.2.3.14. N-(6-Methoxypyridazin-3-yl)pyridinium aminide
2n. Orange solid, mp 115–117 C (ethanol); IR (KBr) nmax (cm1):
1559, 1472, 1418, 1304, 1006, 841, 667; 1H NMR (300 MHz, CD3OD):
d 8.90 (2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 8.33 (1H, tt, J¼7.8 and
1.3 Hz, H4), 8.03 (2H, dd, J¼7.8 and 7.0 Hz, H3(5)), 7.09 (1H, ap d,
J¼9.7 Hz, H40 or H50), 7.02 (1H, ap d, J¼9.7 Hz, H50or H40), 3.88 (3H,
s, CH3);
13C NMR (75 MHz, CD3OD): d 163.2, 160.2, 145.1, 138.5,
128.6, 125.0, 121.6, 54.3. MS (EI, m/z): 202 (32, Mþ), 201 (100), 80
(74), 79 (16), 52 (39); HRMS (ESI-TOF, CH3OH): calcd for C10H11N4O
[MþH]þ, 203.0933; found, 203.0929.
4.2.3.15. N-(6-Chloropyridazin-2-yl)pyridinium aminide 2o. See
Ref. 6j.
4.2.3.16. N-(6-Phenylpyridazin-2-yl)pyridinium aminide 2p. See
Ref. 6j.
4.2.3.17. N-(Pyrimidin-2-yl)pyridinium aminide 2q. See Ref. 6b,j.
4.2.3.18. N-(5-Bromopyrimidin-2-yl)pyridinium aminide 2r. Yellow
solid, mp 126–127 C (dichloromethane/diethyl ether); IR (KBr)
nmax (cm
1): 1575, 1507, 1473, 1436, 1267, 781, 669; 1H NMR
(300 MHz, CD3OD): d 8.75 (2H, dd, J¼6.9 and 1.3 Hz, H2(6)), 8.23
(1H, tt, J¼7.8 and 1.3 Hz, H4), 8.11 (2H, s, H40(60)), 7.93 (2H, dd, J¼7.8
and 6.9 Hz, H3(5)); 13C NMR (75 MHz, CD3OD): d 167.4, 159.2, 145.8,
140.5, 128.7, 103.8. MS (EI, m/z): 252/250 (38/38, Mþ), 251/249
(100/97), 119 (26), 79 (90), 52 (29); HRMS (ESI-TOF, CH3OH): calcd
for C9H8
79BrN4 [MþH]þ, 250.9932; found, 250.9933.
4.2.3.19. N-(2-Chloropyrimidin-4-yl)pyridinium aminide 2s. See
Ref. 6j.
4.2.3.20. N-(2-Methylsulfanylpyrimidin-4-yl)pyridinium aminide
2t. Orange solid, mp 70–71 C (ethyl acetate/hexane); IR (KBr) nmax
(cm1): 1618, 1582, 1502, 1473, 1449, 1368, 1353, 813, 687; 1H NMR
(300 MHz, CD3OD): d 8.72 (2H, dd, J¼6.9 and 1.3 Hz, H2(6)), 8.28
(1H, tt, J¼7.8 and 1.3 Hz, H4), 7.95 (2H, dd, J¼7.8 and 6.9 Hz, H3(5)),
7.66 (1H, d, J¼6.2 Hz, H60), 6.09 (1H, d, J¼6.2 Hz, H50), 2.07 (3H, s,
CH3);
13C NMR (75 MHz, CD3OD): d 171.3, 167.5, 153.2, 146.1, 140.9,
128.4, 102.6, 13.5. MS (EI, m/z): 218 (52, Mþ), 217 (26), 80 (33), 79
(100), 52 (27); HRMS (ESI-TOF, CH3OH): calcd for C10H11N4S
[MþH]þ, 219.0704; found, 219.0721.
4.2.3.21. N-(2-Chloro-6 methylpyrimidin-4-yl)pyridinium aminide
2u. See Ref. 6j.
4.2.3.22. N-(2,6-Dichloropyrimidin-4-yl)pyridinium aminide 2v. See
Ref. 6j.
4.2.3.23. N-(Pyrimidin-5-yl)pyridinium aminide 2w. Orange solid,
mp 131–133 C (ethanol/ethyl acetate); IR (KBr) nmax (cm1): 1458,1431, 719, 626; 1H NMR (300 MHz, CD3OD): d 8.81 (2H, dd, J¼6.9
and 1.2 Hz, H2(6)), 8.23 (1H, s, H20), 8.16 (1H, tt, J¼7.6 and 1.2 Hz,
H4), 7.92 (4H, m, H40 (60) and H3(5)); 13C NMR (75 MHz, CD3OD):
d 151.9, 145.3, 144.2, 140.4, 139.0, 130.0. MS (EI, m/z): 172 (48, Mþ),
80 (99), 66 (100), 52 (40); HRMS (ESI-TOF, CH3OH): calcd for
C9H9N4 [MþH]þ, 173.0827; found, 173.0824.
4.2.3.24. N-(Pyrazin-2-yl)pyridinium aminide 2x. See Ref. 6b,j.
4.2.3.25. N-(3-Chloropyrazin-2-yl)pyridinium aminide 2y. See
Ref. 6j.
4.2.3.26. N-(6-Chloropyrazin-2-yl)pyridinium aminide 2z. See
Ref. 6j.
4.2.3.27. N-(Quinoxalin-2-yl)pyridinium aminide 2aa. Yellow solid,
mp 132–134 C (ethanol/ethyl acetate); IR (KBr) nmax (cm1): 1580,
1541, 1503, 1467, 1430, 1304, 1153, 1011, 928, 754, 666; 1H NMR
(300 MHz, CD3OD): d 8.97 (2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 8.23
(1H, tt, J¼7.9 and 1.3 Hz, H4), 8.21 (1H, s, H30), 7.96 (2H, dd, J¼7.9
and 7.0 Hz, H3(5)), 7.68 (1H, dd, J¼8.2 and 1.5 Hz, H50), 7.42 (1H,
ddd, J¼8.2, 7.0, and 1.5 Hz, H60), 7.28 (1H, dd, J¼8.2 and 1.5 Hz, H80),
7.21 (ddd, J¼8.2, 7.0, and 1.5 Hz, H70); 13C NMR (75 MHz, CD3OD):
d 159.6, 145.0, 144.7, 143.3, 139.8, 137.1, 130.7, 128.7, 128.6, 125.4,
123.5. MS (EI, m/z): 222 (50, Mþ), 221 (100), 143 (15), 116 (28), 79
(12), 52 (12); HRMS (APCI): calcd for C13H11N4 [MþH]þ, 223.0984;
found, 223.1041.
4.2.3.28. N-(Thiazol-2-yl)pyridinium aminide 2ab. Orange solid, mp
95–97 C (ethyl acetate/hexane); IR (KBr) nmax (cm1): 1491, 1444,
1309, 1223, 1162, 757, 667; 1H NMR (300 MHz, CD3OD): d 9.10 (2H,
dd, J¼7.2 and 1.3 Hz, H2(6)), 7.97 (1H, tt, J¼7.6 and 1.3 Hz, H4), 7.79
(2H, dd, J¼7.6 and 7.2 Hz, H3(5)), 6.93 (1H, d, J¼3.8 Hz, H40), 6.50
(1H, d, J¼3.8 Hz, H50); 13C NMR (75 MHz, (CD3)2CO): d 178.8, 141.7,
138.2, 136.2, 128.3, 106.4. MS (EI, m/z): 177 (33, Mþ), 79 (100), 52
(19); HRMS (ESI-TOF, CH3OH): calcd for C8H8N3S [MþH]þ,
178.0439; found, 178.0428.
4.2.3.29. N-(5-Nitrothiazol-2-yl)pyridinium aminide 2ac. Orange
solid, mp 241–242 C (methanol); IR (KBr) nmax (cm1): 1505, 1485,
1473, 1417, 1388, 1317, 1238, 1159, 1110, 750, 667; 1H NMR
(300 MHz, (CD3)2CO): d 9.04 (2H, dd, J¼7.0 and 1.3 Hz, H2(6)), 8.33
(1H, tt, J¼7.7 and 1.3 Hz, H4), 8.06 (2H, dd, J¼7.7 and 7.0 Hz, H3(5)),
7.94 (1H, s, H40); 13C NMR (125 MHz, (CD3)2CO): 179.5, 142.5, 139.5,
133.0, 127.5 (two overlapped signals). MS (EI,m/z): 222 (37, Mþ), 97
(35), 79 (100), 52 (27); HRMS (ESI-TOF, CH3OH): calcd for
C8H7N4O2S [MþH]þ, 223.0290; found, 223.0277.
4.2.3.30. N-(5-Ethoxycarbonylthiazol-2-yl)pyridinium aminide
2ad. Orange solid, mp 125–126 C (ethyl acetate/hexane); IR (KBr)
nmax (cm
1): 1684, 1489,1452,1311, 1276,1234,1164,1074, 770, 749,
670; 1H NMR (300 MHz, CD3OD): d 8.96 (2H, dd, J¼7.0 and 1.3 Hz,
H2(6)), 8.21 (1H, tt, J¼7.8 and 1.3 Hz, H4), 7.94 (2H, dd, J¼7.8 and
7.0 Hz, H3(5)), 7.62 (1H, s, H40), 4.26 (2H, q, J¼7.1 Hz, CH2), 1.34 (3H,
t, J¼7.1 Hz, CH3); 13C NMR (75 MHz, CD3OD): d 183.0, 164.4, 148.5,
144.0, 140.1, 129.0, 113.4, 61.6, 14.7. MS (EI, m/z): 249 (34, Mþ), 97
(22), 79 (100), 52 (38); HRMS (ESI-TOF, CH3OH): calcd for
C11H12N3O2S [MþH]þ, 250.0650; found, 250.0671.Acknowledgements
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